Skip to main content
. 2019 Mar 27;3(7):939–944. doi: 10.1182/bloodadvances.2018028662

Table 1.

Transplant type (or no 7/8 or 8/8 URD/CB transplant) by recipient ancestry divided into recent (January 2012-November 2017) vs earlier (October 2005-December 2011) periods

Patient ancestry group Transplant type, n (%) Total patients, N (%)
8/8 URD* 7/8 URD CB No URD or CB
Early patients 273 (48) 127 (22) 138 (24) 32 (6) 570 (100)
 European (not Southern) 203 (63) 68 (21) 48 (15) 3 (1) 322 (100)
  Northwestern European 77 21 10 1 109
  Eastern 62 18 15 0 95
  Mixed European 64 29 23 2 118
 Southern European 20 (36) 13 (24) 17 (31) 5 (9) 55 (100)
 Non-European (not African) 41 (33) 28 (22) 51 (40) 6 (5) 126 (100)
  Asian 11 11 23 0 45
  White Hispanic 14 12 16 4 46
  Middle Eastern 6 1 4 0 11
  Mixed non-European 10 4 8 2 24
 African 9 (13) 18 (27) 22 (33) 18 (27) 67 (100)
Recent patients 450 (61) 92 (12) 181 (25) 19 (3) 742 (100)
 European (not Southern) 319 (78) 38 (9) 54 (13) 0 (0) 411 (100)
  Northwestern European 121 13 13 0 147
  Eastern 93 9 17 0 119
  Mixed European 105 16 24 0 145
 Southern European 34 (44) 14 (18) 28 (36) 2 (3) 78 (100)
 Non-European (not African) 80 (46) 26 (15) 63 (36) 6 (3) 175 (100)
  Asian 21 4 24 1 50
  White Hispanic 20 11 16 4 51
  Middle Eastern 9 3 7 0 19
  Mixed non-European 30 8 16 1 55
 African 17 (22) 14 (18) 36 (46) 11 (14) 78 (100)
All patients 723 (55) 219 (17) 319 (24) 51 (4) 1312 (100)

Africans included African Americans or African ancestry patients from the Caribbean or Africa. Non-European mixes had at least partial non-European origins excluding those who self-identified as black.

*

Statistical comparisons of receipt of 8/8 HLA-allele matched URD transplants in recent vs early periods: 61% in all recent period patients vs 48% in early patients (P < .001). In ancestry subgroups, the comparisons were European patients (not southern) 78% in recent patients vs 63% in early patients (P < .001), Southern European patients 44% vs 36% (P = .511), non-Europeans (not African) patients 46% vs 33% (P = .029), and African patients 22% vs 13% (P = .275).